Trade Las Vegas Sands Corp - LVS
Las Vegas Sands is a developer and operator of world-class integrated resorts. These resorts offer luxury hospotality, gaming, entertainment and dining services. The company also operates facilities for MICE (Meetings, Incentives, Convention and Exhibition) tourism. Today, the Las Vegas Sands Corporation is expanding its presence worldwide, operating business, leisure property and resorts in Las Vegas, Macao, Bethlehem (Pennsylvania) and Singapore. With a team of 51,000 employees globally, the company provides best-in-class hospitality services to a variety of customers every day.
Las Vegas Sands trades on the New York Stock Exchange under the LVS ticker. View the most current LVS share price chart and tap into the LVS finance at Capital.com.
Latest shares articles

BNP Paribas stock forecast: Q2 earnings beat estimates
BNP Paribas is a French banking group whose recent developments include a Swift ledger transaction with HSBC for Siemens and continued focus on eurozone interest rates. Explore third-party BNP price targets and technical analysis. Past performance is not a reliable indicator of future results.
7 hours ago

Boeing stock forecast: FAA investigates Miami freighter crash
Boeing is a US aerospace manufacturer whose shares remain in focus after a 767-300 freighter crash in Miami prompted an FAA investigation. Explore third-party BA price targets and technical analysis. Past performance is not a reliable indicator of future results.
8 hours ago

CaixaBank stock forecast: BPI exits Angola market
CaixaBank is a Spanish bank whose Portuguese unit, Banco BPI, agreed to sell its 33.35% stake in Banco de Fomento de Angola for €388.5m. Explore third-party CABK price targets and technical analysis. Past performance is not a reliable indicator of future results.
9 hours ago

Valneva stock forecast: EMA validates Lyme vaccine application
Valneva is a French vaccine company listed on Euronext Paris. In August, the EMA validated the marketing-authorisation application for its Lyme disease vaccine candidate with Pfizer. Explore third-party VLA price targets. Past performance is not a reliable indicator of future results.
12 hours ago